SOX2 and non-small cell lung carcinoma: The confirmation of the immune evasion mechanism involving SOX2-OT and the stimulating impact of the SOX2-OT/miR-30d-5p/PDK1 axis on PD-L1, operating via the mTOR signaling pathway, has been demonstrated in NSCLC [108].